钙调神经磷酸酶
他克莫司
医学
移植
肾移植
免疫抑制
重症监护医学
免疫学
外科
作者
Waichi Wong,Jean-Pierre Venetz,NINA E. TOLKOFF-RUBIN,Manuel A. Pascual
出处
期刊:Transplantation
[Wolters Kluwer]
日期:2005-08-01
卷期号:80 (3): 289-296
被引量:60
标识
DOI:10.1097/01.tp.0000168436.76784.45
摘要
The calcineurin inhibitors (CNIs) cyclosporine and tacrolimus have been the cornerstones of immunosuppressive strategies in clinical transplantation. Currently, regimens that are most widely used for induction and maintenance therapy include CNIs. However, many clinical trials aiming at reducing or eliminating CNIs have been performed in recent years. Here, we review and discuss current and future immunosuppressive strategies with a special emphasis on the role of CNIs, in the light of recent studies in the field of kidney transplantation. In the current era, CNIs still play an important role.
科研通智能强力驱动
Strongly Powered by AbleSci AI